Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury.

K, Kashani; A, Al-Khafaji; T, Ardiles; A, Artigas; SM, Bagshaw; M, Bell; A, Bihorac; R, Birkhahn; CM, Cely; LS, Chawla; DL, Davison; T, Feldkamp; LG, Forni; MN, Gong; KJ, Gunnerson; M, Haase; J, Hackett; PM, Honore; EA, Hoste; O, Joannes-Boyau; M, Joannidis; P, Kim; JL, Koyner; DT, Laskowitz; ME, Lissauer; G, Marx; PA, McCullough; S, Mullaney; M, Ostermann; T, Rimmelé; NI, Shapiro; AD, Shaw; J, Shi; AM, Sprague; JL, Vincent; C, Vinsonneau; L, Wagner; MG, Walker; RG, Wilkerson; K, Zacharowski; JA, Kellum

doi:10.1186/cc12503

Public

Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury.

Published in Critical care (London, England) • Feb 6, 2013

NobleIDark:/48914/w1/20260526/27CE5FEBRecord on NobleID

Authors:

Kashani K

,

Al-Khafaji A

,

Ardiles T

Abstract

Introduction Acute kidney injury (AKI) can evolve quickly and clinical measures of function often fail to detect AKI at a time when interventions are likely to provide benefit. Identifying early markers of kidney damage has been difficult due to the complex nature of human AKI, in which multiple eti...

Discussions